GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tactile Systems Technology Inc (NAS:TCMD) » Definitions » Beneish M-Score

Tactile Systems Technology (Tactile Systems Technology) Beneish M-Score

: -2.66 (As of Today)
View and export this data going back to 2016. Start your Free Trial

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.66 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Tactile Systems Technology's Beneish M-Score or its related term are showing as below:

TCMD' s Beneish M-Score Range Over the Past 10 Years
Min: -2.83   Med: -2.25   Max: -1.97
Current: -2.66

During the past 11 years, the highest Beneish M-Score of Tactile Systems Technology was -1.97. The lowest was -2.83. And the median was -2.25.


Tactile Systems Technology Beneish M-Score Historical Data

The historical data trend for Tactile Systems Technology's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tactile Systems Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.98 -2.32 -2.05 -2.83 -2.66

Tactile Systems Technology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.83 -2.54 -2.75 -2.45 -2.66

Competitive Comparison

For the Medical Devices subindustry, Tactile Systems Technology's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tactile Systems Technology Beneish M-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Tactile Systems Technology's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Tactile Systems Technology's Beneish M-Score falls into.



Tactile Systems Technology Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Tactile Systems Technology for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7081+0.528 * 1.0028+0.404 * 0.9311+0.892 * 1.112+0.115 * 0.9153
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9099+4.679 * -0.026951-0.327 * 0.5921
=-2.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $43.2 Mil.
Revenue was 77.652 + 69.586 + 68.339 + 58.846 = $274.4 Mil.
Gross Profit was 56.007 + 49.359 + 48.299 + 41.468 = $195.1 Mil.
Total Current Assets was $145.3 Mil.
Total Assets was $281.4 Mil.
Property, Plant and Equipment(Net PPE) was $25.3 Mil.
Depreciation, Depletion and Amortization(DDA) was $6.5 Mil.
Selling, General, & Admin. Expense(SGA) was $169.2 Mil.
Total Current Liabilities was $41.1 Mil.
Long-Term Debt & Capital Lease Obligation was $44.6 Mil.
Net Income was 8.202 + 22.299 + -0.1 + -1.886 = $28.5 Mil.
Non Operating Income was -0.593 + 2.669 + -0.838 + -0.993 = $0.2 Mil.
Cash Flow from Operations was 18.352 + 4.096 + 13.909 + -0.502 = $35.9 Mil.
Total Receivables was $54.8 Mil.
Revenue was 73.9 + 65.262 + 59.645 + 47.978 = $246.8 Mil.
Gross Profit was 52.097 + 46.794 + 43.223 + 33.862 = $176.0 Mil.
Total Current Assets was $119.8 Mil.
Total Assets was $255.0 Mil.
Property, Plant and Equipment(Net PPE) was $27.4 Mil.
Depreciation, Depletion and Amortization(DDA) was $6.3 Mil.
Selling, General, & Admin. Expense(SGA) was $167.2 Mil.
Total Current Liabilities was $64.3 Mil.
Long-Term Debt & Capital Lease Obligation was $66.8 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(43.173 / 274.423) / (54.826 / 246.785)
=0.157323 / 0.222161
=0.7081

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(175.976 / 246.785) / (195.133 / 274.423)
=0.713074 / 0.711066
=1.0028

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (145.294 + 25.323) / 281.438) / (1 - (119.763 + 27.399) / 254.996)
=0.393767 / 0.422885
=0.9311

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=274.423 / 246.785
=1.112

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.3 / (6.3 + 27.399)) / (6.5 / (6.5 + 25.323))
=0.186949 / 0.204255
=0.9153

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(169.193 / 274.423) / (167.213 / 246.785)
=0.616541 / 0.677565
=0.9099

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((44.612 + 41.057) / 281.438) / ((66.761 + 64.33) / 254.996)
=0.304397 / 0.51409
=0.5921

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(28.515 - 0.245 - 35.855) / 281.438
=-0.026951

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Tactile Systems Technology has a M-score of -2.66 suggests that the company is unlikely to be a manipulator.


Tactile Systems Technology Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Tactile Systems Technology's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Tactile Systems Technology (Tactile Systems Technology) Business Description

Traded in Other Exchanges
Address
3701 Wayzata Boulevard, Suite 300, Minneapolis, MN, USA, 55416
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
Executives
Boyd Vindell Washington director 1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
Daniel L. Reuvers director, officer: President and CEO INTEGRA LIFESCIENCES CORPORATION, 311 ENTERPRISE DRIVE, PLAINSBORO NJ 08536
Sherri Lee Ferstler officer: Senior VP, Sales 1331 TYLER STREET NE, STE 200, MINNEAPOLIS MN 55413
William W Burke director 3868 MOCKINGBIRD LN, DALLAS TX 75205
Kristie Burns officer: Sr. VP Mktg & Clinical Affairs 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Eric Pauls officer: Senior VP, Sales 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Elaine M. Birkemeyer officer: Chief Financial Officer 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Brent Moen officer: Chief Financial Officer 3600 HOLLY LANE NORTH, SUITE 40, PLYMOUTH MN 55447
Carmen B Volkart director C/O MODULAR MEDICAL, INC., 16772 WEST BERNARDO DRIVE, SAN DIEGO CA 92127
Valerie L. Asbury director 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
David Brent Shafer director 2800 ROCKCREEK PARKWAY, NORTH KANSAS CITY MO 64117
Bryan Rishe officer: Vice President, Sales 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413
Deepti Jain director 3701 WAYZATA BLVD, MINNEAPOLIS MN 55416
Sheri Louise Dodd director 3701 WAYZATA BLVD, SUITE 300, MINNEAPOLIS MN 55416
Gerald R. Mattys director, officer: Chief Executive Officer 1331 TYLER STREET NE, SUITE 200, MINNEAPOLIS MN 55413

Tactile Systems Technology (Tactile Systems Technology) Headlines

From GuruFocus

Tactile Medical to Present at Two Upcoming Conferences in March

By sperokesalga sperokesalga 03-02-2023

Insider Alert: An Insider Just Sold Tactile Systems Technology Inc Shares

By GuruFocus Research GuruFocus Editor 03-01-2023